suxethonium

Description

suxethonium: RN given refers to parent cpd [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Synonym
med638szqb ,
suxethonium
67724-50-9
ethanaminium, 2,2'-((1,4-dioxo-1,4-butanediyl)bis(oxy)bis(n-ethyl-n,n-dimethyl-
unii-med638szqb
n,n'-(2,2'-(succinyldioxy)diethyl)bis-ethyldimethyl ammonium hydroxide
2,2'-[(1,4-dioxobutane-1,4-diyl)bis(oxy)]bis(n-ethyl-n,n-dimethylethanaminium)
ethyl(2-hydroxyethyl)dimethylammonium succinate
suxethonium ion
suxethonium [who-dd]
suxethonium cation
SCHEMBL487808
CHEMBL2111153
Q27283954
DTXSID30866398

[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Timeframe	Studies, This Drug (%)	All Drugs %
pre-1990	6 (100.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Publication Type	This drug (%)	All Drugs (%)
Trials	1 (14.29%)	5.53%
Reviews	0 (0.00%)	6.00%
Case Studies	0 (0.00%)	4.05%
Observational	0 (0.00%)	0.25%
Other	6 (85.71%)	84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Substance	Relationship Strength	Studies	Trials	Classes	Roles
succinylcholine Succinylcholine: A quaternary skeletal muscle relaxant usually used in the form of its bromide, chloride, or iodide. It is a depolarizing relaxant, acting in about 30 seconds and with a duration of effect averaging three to five minutes. Succinylcholine is used in surgical, anesthetic, and other procedures in which a brief period of muscle relaxation is called for.. succinylcholine : A quaternary ammonium ion that is the bis-choline ester of succinic acid.	4.57	6	1	quaternary ammonium ion; succinate ester	drug allergen; muscle relaxant; neuromuscular agent
cardiovascular agents Cardiovascular Agents: Agents that affect the rate or intensity of cardiac contraction, blood vessel diameter, or blood volume.	1.93	1	0

Condition	Relationship Strength	Studies	Trials
Apnea A transient absence of spontaneous respiration.	1.93	1	0
Muscle Pain [description not available]	2.34	2	0
Anesthesia A state characterized by loss of feeling or sensation. This depression of nerve function is usually the result of pharmacologic action and is induced to allow performance of surgery or other painful procedures.	1.93	1	0
Myalgia Painful sensation in the muscles.	2.34	2	0
Disease A definite pathologic process with a characteristic set of signs and symptoms. It may affect the whole body or any of its parts, and its etiology, pathology, and prognosis may be known or unknown.	1.93	1	0
Muscle Disorders [description not available]	1.93	1	0
Muscular Diseases Acquired, familial, and congenital disorders of SKELETAL MUSCLE and SMOOTH MUSCLE.	1.93	1	0
Acute Post-operative Pain [description not available]	1.93	1	0
Pain, Postoperative Pain during the period after surgery.	1.93	1	0
Chronic Kidney Failure [description not available]	3.34	1	1
Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION.	3.34	1	1